MedPath
TGA Approval

APO-RIVASTIGMINE rivastigmine (as hydrogen tartrate) 3mg capsule blister pack (160578)

160578

APO-RIVASTIGMINE rivastigmine (as hydrogen tartrate) 3mg capsule blister pack

Arrotex Pharmaceuticals Pty Ltd

July 27, 2010

Medicine

Medicine

Active

Registered

Active Ingredients

rivastigmine hydrogen tartrate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

APO-RIVASTIGMINE rivastigmine (as hydrogen tartrate) 3mg capsule blister pack (160578) - TGA 批准文号 | MedPath